Anavex Life Sciences (AVXL) Operating Income (2021 - 2026)
Anavex Life Sciences (AVXL) posted Operating Income of $6.74 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$14.46 million a year earlier.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Operating Income (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Operating Income at Anavex Life Sciences was -$17.37 million; for FY2025 (ended Sep 30, 2025), it was -$51.41 million.
- In prior fiscal years, Anavex Life Sciences' Operating Income was -$52.88 million in FY2024, -$55.76 million in FY2023, -$50.99 million in FY2022 and -$42 million in FY2021.
- The fiscal Q3 2026 figure stands as the highest quarterly Operating Income in data going back to fiscal Q1 2022.
- According to Business Quant data, Operating Income for the three prior fiscal quarters was -$6.48 million (Q2 2026), -$6.78 million (Q1 2026) and -$10.84 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Anavex Life Sciences | 168.71 Mn | -311.37 Mn | - | 6.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.74 Mn |
| Mar 31, 2026 | -6.48 Mn |
| Dec 31, 2025 | -6.78 Mn |
| Sep 30, 2025 | -10.84 Mn |
| Jun 30, 2025 | -14.46 Mn |
| Mar 31, 2025 | -12.51 Mn |
| Dec 31, 2024 | -13.59 Mn |
| Sep 30, 2024 | -14.27 Mn |
| Jun 30, 2024 | -14.60 Mn |
| Mar 31, 2024 | -12.62 Mn |
| Dec 31, 2023 | -11.38 Mn |
| Sep 30, 2023 | -12.66 Mn |
| Jun 30, 2023 | -13.53 Mn |
| Mar 31, 2023 | -14.19 Mn |
| Dec 31, 2022 | -15.38 Mn |
| Sep 30, 2022 | -15.28 Mn |
| Jun 30, 2022 | -12.46 Mn |
| Mar 31, 2022 | -11.52 Mn |
| Dec 31, 2021 | -11.72 Mn |
API Access
Anavex Life Sciences Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();